Is Protalix BioTherapeutics, Inc. (PLX) a Buy, Sell, or Hold?
AMEX : PLX
Protalix BioTherapeutics, Inc. — Competitors
$2.615 USD
$0.19 (7.84%)
- Volume
- 2M
- Average Volume
- 697.46K
- Market Capitalization
- $210.69M
- P/E Ratio
- 10.85
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.19
- Year Low
- $1.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.94
PLX vs. The Competition
| Properties | PLX | CDXS | CHRS | GNFT |
|---|---|---|---|---|
| Market Cap | $210.69M | $172.1M | $180.77M | $445.68M |
| Shares Outstanding | $80.57M | $107.56M | $154.5M | $49.8M |
| P/E Ratio | 10.85 | -4.76 | -1.15 | 258.86 |
| EPS | 0.24 | -0.34 | -0.85 | 0.03 |
| Day Low | 2.4 | 1.48 | 1.17 | 8.85 |
| Day High | 2.705 | 1.66 | 1.24 | 9 |
| Year Low | 1.46 | 0.96 | 0.92 | 2.55 |
| Year High | 3.19 | 3.87 | 2.616 | 10 |
| Average Price 50 | 2.2568 | 2.1652 | 1.446 | 4.1215 |
| Average Price 200 | 2.22165 | 1.9316 | 1.58605 | 3.94435 |
| Volume | 2M | 1.58M | 1.14M | 4213 |
| Average Volume | - | - | - | - |